GLOBUS MEDICAL, INC. (GMED) Gross profit 2016–2025
GLOBUS MEDICAL, INC. (GMED) annual gross profit history from SEC filings — each fiscal year as reported.
$2.0BFY2025 · since FY2016: $429.3M → $2.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0B | +33.5% |
| FY2024 | $1.5B | +45.4% |
| FY2023 | $1.0B | +34.4% |
| FY2022 | $759.1M | +5.6% |
| FY2021 | $718.9M | +25.8% |
| FY2020 | $571.6M | -5.6% |
| FY2019 | $605.4M | +9.4% |
| FY2018 | $553.6M | +14.0% |
| FY2017 | $485.5M | +13.1% |
| FY2016 | $429.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross marginGMED Operating incomeGMED Operating marginGMED Operating cash flowGMED Free cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →